ChristianESandrockMD
Pulmonology • Sacramento, CACritical Care Medicine, Infectious Disease
Associate Professor, Internal Medicine, UC, Davis School of Medicine
Dr. Sandrock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3000 Q St
Sacramento, CA 95816Phone+1 916-733-3304Fax+1 916-733-5383
Education & Training
University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003- University of California Davis HealthFellowship, Infectious Disease, 1999 - 2001
- University of California Davis HealthResidency, Internal Medicine, 1996 - 1999
Georgetown University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1997 - 2024
HI State Medical License 2013 - 2018- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 Start of enrollment: 2020 Oct 01
Publications & Presentations
PubMed
- 34 citationsCutting Edge: Vasostatin-1–Derived Peptide ChgA29–42 Is an Antigenic Epitope of Diabetogenic BDC2.5 T Cells in Nonobese Diabetic MiceEnayat Nikoopour, Christian Sandrock, Katrina Huszarik, Olga Krougly, Edwin Lee-Chan
Journal of Immunology. 2011-04-01 - 34 citationsAvian influenza viruses in wild birds: A moving targetWalter M. Boyce, Christian Sandrock, Chris Kreuder-Johnson, Terra R. Kelly, Carol J. Cardona
Comparative Immunology, Microbiology and Infectious Diseases. 2009-07-01 - 14 citationsTreatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.Pierluigi Viale, Christian E Sandrock, Paula Ramirez, Gian Maria Rossolini, Thomas P Lodise
Annals of Intensive Care. 2023-06-15
Press Mentions
Is the Risk of Getting Long-Term COVID Decreasing? That’s What the Experts SayMarch 18th, 2023- Is the Risk of Getting Long COVID Declining? Here’s What Experts SayMarch 17th, 2023
- Lower Respiratory Tract Infection in Early Childhood Linked with Higher Risk of Dying from Respiratory Disease as an Adult, Study FindsMarch 8th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
